advisorsecurities master

ATAIAtaiBeckley Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
11993
Ticker
ATAI
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-06-18
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ATAI

Detail

Enriched 2026-08-14 20:47

Market cap
$2,681,351,556.87
Shares outstanding (class)
368,166,674
Shares outstanding (weighted)
370,864,669
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
99
Location
NEW YORK, NY
Description

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data